Esophageal Squamous Cell Cancer Clinical Trials

16 clinical trials for Esophageal Squamous Cell Cancer across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma — RECRUITING · NA
• A Study of MGC026 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• Study of XB010 in Subjects With Solid Tumors — RECRUITING · PHASE1
• A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4 — RECRUITING · PHASE1
• Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors — TERMINATED · PHASE1
• A Single-center, Single-arm Clinical Study Evaluating the Short-term Efficacy of Inflatable Mediastinoscopic-assisted Transhiatal Laparoscopic Esophagectomy for the Radical Resection of Thoracic Esophageal Cancer — COMPLETED · NA
• Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE2
• CT and Endoscopic Biopsy Image-Based Deep Learning for Predicting Left Recurrent Laryngeal Nerve Lymph Node Metastasis in Esophageal Cancer — ACTIVE_NOT_RECRUITING
• A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands — COMPLETED · PHASE1
• Toripalimab with Paclitaxel and Cisplatin As Neoadjuvant Treatment for Esophageal Squamous Cell Carcinoma — TERMINATED · PHASE2
• Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy — TERMINATED · PHASE2
• Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer — TERMINATED · PHASE3
• Sequential Paclitaxel Chemotherapy and Radiotherapy as 1st Line Treatment for Elderly Esophageal Squamous Cell Cancer — OTHER · PHASE2
• Sequential Paclitaxel Plus Cisplatin Chemotherapy and Radiotherapy as 1st Line Treatment for Esophageal Squamous Cell Cancer — OTHER · PHASE2
• Study of Nimotuzumab to Treat Esophageal Squamous Cell Carcinoma. — OTHER · PHASE1
• Nimotuzumab Plus Paclitaxel and Cisplatin as 1st Line Treatment for Esophageal Squamous Cell Cancer — OTHER · PHASE2

Refine this search